SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Morgen, K
Right arrow Articles by McFarland, H F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgen, K
Right arrow Articles by McFarland, H F
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ring-enhancement in multiple sclerosis: marker of disease severity

K Morgen

Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

N O Jeffries

Biostatistics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

R Stone

Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

R Martin

Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

N D Richert

Laboratory for Diagnostic Radiology Research, National Institutes of Health, Bethesda, Maryland, USA

J A Frank

Laboratory for Diagnostic Radiology Research, National Institutes of Health, Bethesda, Maryland, USA

H F McFarland

Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA

Correlations between conventional MRI measures of disease activity and clinical disability in multiple sclerosis (MS) have been disappointing. Because ring-enhancing lesions may reflect a more destructive pathology, we tested their potential association with disease severity. We evaluated active lesions with regard to their enhancement pattern on serial magnetic resonance images in a cohort of 28 patients with relapsing-remitting MS. The percentage of ring-enhancing lesions correlated with EDSS, T2 lesion load and duration of disease and predicted the occurrence of relapses during the baseline period of observation as well as after 3 years of follow-up in multiple logistic regression analysis. The findings suggest that the pathological process reflected by ring-enhancing lesions may contribute to more severe clinical disease.

Key Words: multiple sclerosis • magnetic resonance • ring-enhancing lesions • enhancement pattern

Multiple Sclerosis, Vol. 7, No. 3, 167 (2001)
DOI: 10.1177/135245850100700306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
A. Boster, S. Hreha, J. R. Berger, F. Bao, R. Penmesta, A. Tselis, C. Endress, I. Zak, J. Perumal, C. Caon, et al.
Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol, May 1, 2009; 66(5): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
F. B. Konig, B. Wildemann, S. Nessler, D. Zhou, B. Hemmer, I. Metz, H.-P. Hartung, B. C. Kieseier, and W. Bruck
Persistence of Immunopathological and Radiological Traits in Multiple Sclerosis
Arch Neurol, November 1, 2008; 65(11): 1527 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, A J Thompson, and D H Miller
Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study
Multiple Sclerosis, March 1, 2007; 13(2): 178 - 185.
[Abstract] [PDF]


Home page
Mult SclerHome page
J N. Zwemmer, J Berkhof, J A Castelijns, F Barkhof, C H Polman, and B M. Uitdehaag
Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics
Multiple Sclerosis, September 1, 2006; 12(5): 565 - 572.
[Abstract] [PDF]


Home page
BrainHome page
J. Wuerfel, J. Bellmann-Strobl, P. Brunecker, O. Aktas, H. McFarland, A. Villringer, and F. Zipp
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study
Brain, January 1, 2004; 127(1): 111 - 119.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Bagnato, N. Jeffries, N. D. Richert, R. D. Stone, J. M. Ohayon, H. F. McFarland, and J. A. Frank
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years
Brain, August 1, 2003; 126(8): 1782 - 1789.
[Abstract] [Full Text] [PDF]



Advertisement